库尔库明的药理作用,配方和临床研究进展
Minghui Hao1, Chungang Zhang1,2,3, Ti Wang1
1College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, China.
Frontiers in pharmacology
|April 1, 2025
概括
来自黄的黄素对各种疾病具有前景,但面临生物可用性挑战. 先进的配方正在改善其在糖尿病和关节炎等疾病的临床试验中的使用.
科学领域:
- 药理学和传统医学的医学.
- 药物输送系统 药物输送系统
- 临床研究 临床研究
背景情况:
- 黄是一种来自黄的化合物,具有显著的抗癌,抗炎,抗氧化和抗病毒特性.
- 库尔库明的临床使用受到溶解性和生物可用性差的限制.
- 新的配方策略正在开发中,以提高黄素的治疗效果.
研究的目的:
- 审查黄素的药理机制.
- 总结一下黄素配方开发的进展情况.
- 提供关于黄素临床试验进展的全面概述.
主要方法:
- 国内和国际研究的文献综述.
- 对药理学活动和机制的分析.
- 检查各种配方技术 (纳米配方,固体分散,微球).
- 临床试验阶段和治疗领域的概述.
主要成果:
- 配方的改进增强了黄素的治疗效果.
- 临床研究已经从早期阶段 (I/II) 到后期阶段 (III/IV) 的试验.
- 关键的试验领域包括代谢综合征,糖尿病,肥胖,口腔/牙科疾病和关节炎.
结论:
- 先进的黄素配方正在克服生物可用性问题.
- 黄素的临床应用正在扩大,后期试验也在增加.
- 进一步的研究继续探索黄素在各种疾病中的治疗潜力.
更多相关视频
相关概念视频
Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Preclinical Development: Overview
4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
Drug Administration and Therapy Phases: Overview
391
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
391
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K


